期刊文献+

不同透析龄腹膜透析患者的临床特征分析 被引量:2

Clinical characteristics of long-term survivors and short-term survivors on peritoneal dialysis
原文传递
导出
摘要 目的通过长期与短期腹膜透析患者的对比,找寻影响腹膜透析透析龄的临床特征,从而有利于腹膜透析患者的管理。方法选取2006-01-01—2011-12-31长期在浙江大学医学院附属第一医院肾脏病中心诊断为CKD 5期,进行腹膜透析治疗且能够规律性随访时间1年以上的维持性腹膜透析患者,透析时间为4年以上且仍在透析的定义为长期透析;透析时间小于4年定义为短期透析。接受肾脏移植者,腹膜透析时间小于1年但目前仍在随访的患者不包括在内。符合长期透析标准的有50例(A组),由于死亡退出透析的有55例(B组),转血液透析退出的有90例(C组),回顾性分析对比3组患者的临床特征(包括一般情况、生化指标、透析充分性及残肾功能等)。结果平均随访时间A组为(58.33±10.03)个月;B组为(27.15±9.35)个月;C组为(41.65±12.80)个月。A组年龄[(53.06±16.77)岁]与C组年龄[(54.19±16.71)岁]明显较B组[(62.59±14.79)岁]年轻(P<0.01);A组患糖尿病较B组少[8%(4/50)对23.6(13/55),P<0.05];开始透析时血清白蛋白A组[(38.74±4.65)g/L]比B组[(36.15±4.85)g/L]和C组[(35.23±5.27)g/L]高(P<0.01);C组血糖比A组和B组低(P<0.05),B组C-反应蛋白(CRP)较A组和C组高(P<0.01和P<0.05);A组标准化蛋白氮呈现率(nPNA)较B组高(P<0.05),各组间血脂、血红蛋白、全段甲状旁腺激素(iPTH)和钙磷指标差异无统计学意义。开始透析1个月后A组残肾Kt/V、总Ccr、残肾Ccr、尿量均较B组和C组高(P<0.05),超滤量A组较B组和C组少(P<0.05和P<0.01),脉压差A组和C组较B组少(P<0.05),各组间腹膜转运功能、血糖升高发生率差异均无统计学意义。结论与短期透析患者相比,长期腹膜透析患者具有相对年轻、合并糖尿病发生率较少、开始透析时营养状态较好、炎症水平较低(以CRP为指标)、残余肾功能较好、超滤量较少、舒张压低及脉压差较小的特点。 Objective To evaluate the characteristics of patients on long-term and short-term peritoneal dialysis (PD). Methods Patients who were treated with PD since 2006 to 2011 and on PD for at least one year in our Department of kid-ney disease were included in this study. According to dialysis duration, patients were divided into tree groups. Group A (long-term) was defined as patients survived on PD for more than 4 years. Group B (short-term)was defined as patients who died and Group C (short-term)was defined as switched to hemodialysis within 4 years. Demography, biochemical indexes, di-alysis adequacy, residual renal function were compared between those groups. Results There were 50 patients in group A, 55 patients in group B and 90 patients in group C. Mean followed-up period of group A,group B and group C was (58.33 ± 10.03 ) months, (27. 15 ± 9.35) months and (41.65 ± 12. 80) months, respectively. Younger ( group A [ 53.06 ± 16. 77 ] yrs and group C [54. 19 ± 16. 71 ] yrs vs group B [62. 59 ± 14. 79] yrs,P 〈 0. 01 ) ,fewer episodes of diabetic comorbidity ( group A 4/50 vs group B 13/55, P 〈 0. 05 ) were found in group A. Compared to group B and group C, the level of serum albumin at the beginning of PD was much higher in group A (group A[ 38.74 ± 4. 65 ] g/L vs group B [ 36. 15 ±4. 85 ] g/L and vs group C [ 35.23 ± 5.27 ] g/L,P 〈 0. 01 ). Compared to group A and group B, the levels of blood sugar in group C is lower. The levels of CRP in group B is higher than in group A and group C(P 〈0. 01 and P 〈 0. 05). The levels of nPNA in group A is higher than in group B(P 〈 0. 05 ). The levels of TC, TG, hemoglobin, calcium, phosphate and iPTH were not significantly different between three groups. Renal Kt/V, renal Ccr and urinary volume at the beginning of dialysis were much higher in group A( P 〈 0. 05 ). Uhrafiltration volume and pulse pressure difference was less in group A (P 〈 0. 05 ). Peritonitis morbidity, peritoneal membrane transport,increased blood sugar morbidity were not significantly different between three groups. Conclnsion In comparison to short-term survivors,long-term PD patients are characterized by being younger, less diabetic disease, higher level of serum albumin and hemoglobin, higher volume of urine ,lower level of CRP, better re-sidual renal function , less ultrafihraion and lower pulse pressure difference.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第9期724-727,共4页 Chinese Journal of Practical Internal Medicine
关键词 腹膜透析 透析龄 营养 残肾功能 peritoneal dialysis duration nutrition residual renal function
  • 相关文献

参考文献14

  • 1Cancarini GC, Sandrini M, et al. Long-teIm peritoneal dialysis out- come in a single center [ J ]. Perit Dial Int, 2000,20 ( Suppl 2 ) : S 121 - 126.
  • 2Abdel-Rahman EM, Wakcen M, et al. Characteristics of long term peritoneal dialysis survivors :18 years experience in one center[ J]. Perit Dial Int, 1997,17 (2) : 151 - 156.
  • 3Maitra S, Burkart J, et al. Patients Oil chronic peritoneal dialysis for ten years or more in Nor & America [ J ]. Petit Dial Int, 2000,20 (Suppl 2) :S127 - S133.
  • 4Yang X, Yu XQ. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis : A 5-year clini- cal cohort study [ J ]. Diabetes research and clinical practice, 2013, 100:354 - 361.
  • 5Fried L. Higher membrane permeability predicts poorer patient sur- vival[ J]. Petit Dial Int, 1997,17:387 - 389.
  • 6Klaasen P,Lowtie EG,Reddan DN,et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodial- ysis[ J]. JAMA ,2002,287 : 1548 - 1555.
  • 7Wang AY, Lam CW. Long-term nmrtality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of in- flammation and calcification markers [ J ]. Nephrol Dial Transplant, 2009,24:3826 - 3833.
  • 8Wang AY,Woo J,Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? [ Jl. J Am Soc Nephrol,2003,14 : 1871 - 1879.
  • 9Iseki K, Tozawa M,Yoshi S,et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients [ J]. Nephrol Dial Transplant, 1999,14 : 1956 - 1960.
  • 10Chung SH, Heimbirger O. Association between residual renal func- tion, inflammation and patient survival in new peritoneal dialysis patients [ J ]. Nephrol Dial Transplant,2003,18 ( 3 ) :590 - 597.

二级参考文献24

  • 1马祖等,郑智华,张涤华,叶任高,郝元涛,娄探奇,毛晓玲,刘岩,张弘,汪华林,付君舟,余学清.血液透析患者生存质量的多中心研究[J].中国血液净化,2004,3(7):380-384. 被引量:95
  • 2马祖等,郑智华,叶任高,张涤华,吴培根,沈清瑞,余学清.血液透析患者营养状况的评估方法研究[J].新医学,2004,35(10):600-601. 被引量:27
  • 3马祖等,郑智华,张涤华,郝元涛,叶任高,娄探奇,毛晓玲,刘岩,刘冠贤,朱起之,张增华,汪华林,傅君舟,余学清.血液透析和腹膜透析患者生存质量的多中心调查[J].中华肾脏病杂志,2004,20(6):400-405. 被引量:87
  • 4Chung SH, Heimbiirger O, Lindholm B. Peritoneal dialysis patient survival:a comparison between a Swedish and a Korean centre [ J ]. Nephrology Dialysis Transplantation,2005,20 ( 6 ) : 1207 - 1213.
  • 5Strippoli GFM,Tong A, Johnson D, et al. Catheter-related interven- tions to prevent peritonitis in peritoneal dialysis:a systematic review of randomized, controlled trials[ J]. Journal of the American Society of Nephrology,2004,15 (10) :2735 - 2746.
  • 6Troidle L,Watnick S,Wuerth DB, et al. Depression and its associa- tion with peritonitis in long-term peritoneal dialysis patients [ J ]. A- merican Journal of Kidney Diseases,2003,42 ( 2 ) :350 - 354.
  • 7McDonald SP, Collins JF, Rumpsfeld M, et al. Obesity is a risk fac- tor for peritonitis in the Australian and New Zealand peritoneal dial- ysis patient populations [ J ]. Peritoneal Dialysis International,2004, 24(4) :340 -346.
  • 8Nessim S J, Bargman JM,Austin PC, et al. Predictors of peritonitis in patients on peritoneal dialysis:results of a large, prospective Canadi- an database[J]. Clinical Journal of the American Society of Neph- rology ,2009,4 (7) : 1195 - 1200.
  • 9Lobo JV, Villar KR, de Andrade J'unior MP, et al. Predictor factors of peritoneal dialysis-related peritonitis [ J]. Jomal Brasileiro de Ne- frologia,2010,32(2) :156 - 164.
  • 10Oygar DD, Yalin AS, Altiparmak MR, et al. Obligatory referral a- mong other factors associated with peritonitis in peritoneal dialysis patients [ J ]. Nefroiogia,2011,31 ( 4 ) :435 - 440.

共引文献58

同被引文献22

  • 1者星炜,罗洁,刘振华,白云凯,熊丽炎,单亦升,程磊,田信奎,汪涛.不同超滤功能的持续不卧床腹膜透析患者腹膜液体转运功能评估[J].中国血液净化,2012,11(5):241-244. 被引量:1
  • 2俞雨生,张炯,王金泉,胡伟新,唐政,黎磊石.残余肾功能状态对腹膜透析效能的影响[J].肾脏病与透析肾移植杂志,2006,15(6):520-524. 被引量:26
  • 3Argentino G, Russo R, Maresca ID,et al. Imaging of the peritoneum evalu-ated by 99mTc-Ieodextrin seintigraphy in peritoneal dialysis patients:pre- liminary data [J]. Blood Pufif,2014;38(3-4) :219-23.
  • 4Krediet RT, Boeschoten EW, Zuyderhoudt FM,et al. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal di- alysis patients [ J ]. Blood Purif, 1986 ;4 (4) : 194-203.
  • 5Tzeng HE,Tsai CH, Chang ZL, et al. Interleukin-6 induces vascular en- dothelial growth factor expression and promotes angiogenesis through ap- optosis signal-regulating kinase 1 in human osteosarcoma [ J]. Biochem Pharmacol,2013 ;85 (4) :531-40.
  • 6Pawlaczyk K, Polubinska A, Numata N, et al. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation [ J ]. Int J Artif Organs,2008 ;31 (6) :535-44.
  • 7Prrez Fontan M, Rodriguez-Carmona A, Gareia-Naveiro R, et al. Perito- nitis-related mortality in patients undergoing chronic peritoneal dialysis [ J ]. Petit Dial Int,2005 ;25 ( 3 ) :274-84.
  • 8Hamasaki Y, Doi K,Tanaka M, et al. Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution[J]. BMC Nephrol, 2014 ; 15 : 173.
  • 9谢红浪,刘志红,季大玺,徐斌,黎磊石.糖尿病肾病维持性血液透析长期生存率及其相关因素分析[J].肾脏病与透析肾移植杂志,2008,17(5):401-407. 被引量:33
  • 10戴慧莉,林爱武,钱家麒,方炜,倪兆慧,曹励欧,林星辉,吴青伟.艾考糊精腹膜透析液改善持续非卧床腹膜透析患者的新生血管化[J].中华医学杂志,2010,90(40):2843-2847. 被引量:4

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部